Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cerus (CERS) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Cerus (CERS) over the last 17 years, with Q3 2025 value amounting to $15.7 million.

  • Cerus' Cash & Equivalents fell 2736.96% to $15.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.7 million, marking a year-over-year decrease of 2736.96%. This contributed to the annual value of $20.3 million for FY2024, which is 7400.19% up from last year.
  • Latest data reveals that Cerus reported Cash & Equivalents of $15.7 million as of Q3 2025, which was down 2736.96% from $16.0 million recorded in Q2 2025.
  • Over the past 5 years, Cerus' Cash & Equivalents peaked at $78.5 million during Q3 2021, and registered a low of $11.6 million during Q4 2023.
  • Its 5-year average for Cash & Equivalents is $30.6 million, with a median of $21.6 million in 2024.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first skyrocketed by 17101.9% in 2021, then tumbled by 6726.99% in 2023.
  • Quarter analysis of 5 years shows Cerus' Cash & Equivalents stood at $48.8 million in 2021, then decreased by 27.02% to $35.6 million in 2022, then tumbled by 67.27% to $11.6 million in 2023, then skyrocketed by 74.0% to $20.3 million in 2024, then fell by 22.68% to $15.7 million in 2025.
  • Its Cash & Equivalents was $15.7 million in Q3 2025, compared to $16.0 million in Q2 2025 and $19.5 million in Q1 2025.